SUSMED,Inc. (TYO:4263)

Market Cap	16.96B +71.6%
Revenue (ttm)	480.00M +220.0%
Net Income	-257.00M
EPS	-15.28
Shares Out	16.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,300
Average Volume	263,085
Open	978.00
Previous Close	985.00
Day's Range	967.00 - 1,013.00
52-Week Range	413.00 - 1,231.00
Beta	1.37
RSI	51.39
Earnings Date	May 8, 2026

About SUSMED,Inc.

SUSMED,Inc. develops and sells therapeutic applications in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. It also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 43
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4263

Financial Performance

In fiscal year 2025, SUSMED,Inc.'s revenue was 462.00 million, an increase of 35.09% compared to the previous year's 342.00 million. Losses were -298.00 million, -16.53% less than in 2024.